Unlocking the power of mushroom microdosing to improve mental health
A recent study conducted on rats has shed light on the therapeutic potential of psilocybin microdosing, offering new hope for individuals struggling with various mental health conditions. Psilocybin, a compound found in psychedelic mushrooms, has long been associated with altered states of consciousness. Still, this research delves into the effects of microdoses, which are sub-perceptual and well below the psychedelic threshold.
Microdosing involves taking tiny, controlled amounts of a psychedelic substance, such as psilocybin, on a regular basis. The research involved administering low, non-psychedelic doses of psilocybin to rats, aiming to mimic the microdosing regimens reported by human users. Surprisingly, the rats tolerated the treatment well and did not display negative side effects typically associated with psychedelics, such as anxiety or altered behavior.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.